Tang Kevin C Jounce Therapeutics, Inc. (JNCE) insider trading activity

JNCE Quotes by TradingView

TANG KEVIN C Transaction History

Date Transaction Value Shares Traded Form
May 03 2023
SELL
Disposition due to a tender of shares in a change of control transaction
$9,805,160 $1.85 p/Share
5,300,087
May 03 2023
BUY
Other acquisition or disposition
$97,377,000 $9737.7 p/Share
10,000
Mar 14 2023
BUY
Open market or private purchase
$20,691 $1.02 p/Share
20,286
Mar 13 2023
BUY
Open market or private purchase
$65,043 $0.99 p/Share
65,701

Also insider at

AUPH
Aurinia Pharmaceuticals Inc. Healthcare
OMIC
Singular Genomics Systems, Inc. Healthcare
HRTX
HERON THERAPEUTICS, INC. Healthcare
Director
RAIN
Rain Therapeutics Inc. Healthcare
TCRR
TCR2 THERAPEUTICS INC. Healthcare
LJPC
LA JOLLA PHARMACEUTICAL CO Healthcare
Director
APVO
Aptevo Therapeutics Inc. Healthcare
ODTC
Odonate Therapeutics, Inc. Financial Services
Chief Executive Officer
TKC

Tang Kevin C

Director
San Diego, CA

Track Institutional and Insider Activities on JNCE

Follow Jounce Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JNCE shares.

Notify only if

Insider Trading

Get notified when an Jounce Therapeutics, Inc. insider buys or sells JNCE shares.

Notify only if

News

Receive news related to Jounce Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on JNCE